SignatureFD’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

SignatureFD’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$17K	–	2150
2018 Q3	$17K	Hold	10,000	–	–	﹤0.01%	1230
2018 Q2	$17K	Hold	10,000	–	–	﹤0.01%	1231
2018 Q1	$18K	Hold	10,000	–	–	﹤0.01%	1078
2017 Q4	$22K	Hold	10,000	–	–	﹤0.01%	348
2017 Q3	$29K	Hold	10,000	–	–	﹤0.01%	316
2017 Q2	$45K	Hold	10,000	–	–	0.01%	293
2017 Q1	$47K	Hold	10,000	–	–	0.01%	284
2016 Q4	$61K	Hold	10,000	–	–	0.01%	230
2016 Q3	$55K	Hold	10,000	–	–	0.01%	513
2016 Q2	$38K	Hold	10,000	–	–	0.01%	538
2016 Q1	$28K	Hold	10,000	–	–	﹤0.01%	577
2015 Q4	$57K	Buy	+10,000	New	+$61K	0.01%	347

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SignatureFD's SGYP Position: Q4 2018 in Review

SignatureFD sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 10,000 shares — an estimated $17K sold.

SignatureFD first reported a position in SGYP in Q4 2015 and held it in 12 quarters. The position peaked at $61K in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

SignatureFD reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
SignatureFD sold 10,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $17K.
SignatureFD first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 12 quarters.
SignatureFD's Synergy Pharmaceuticals, Inc Common Stock position peaked at $61K in Q4 2016.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on SignatureFD's 13F filing for Q4 2018, filed 13 Feb 2019.